Quercetin Alleviates Cardiac Fibrosis via Regulating the SIRT3 Signaling Pathway
Cardiovascular Drugs and Therapy · 2025
DOI: 10.1007/s10557-024-07658-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Drugs and Therapy, 2025. Verfasst von Da-Wei Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xinhua Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Quercetin, Sirtuin 3, Fibroblasts, Myocardium. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission, High-level University Construction Project of Shanghai City.
Abstract (Originalsprache)
PURPOSE: Cardiovascular diseases, exacerbated by cardiac fibrosis, are the leading causes of mortality. We aimed to determine the role of quercetin (QU) in cardiac fibrosis and the underlying mechanism. METHODS: In this study, 8-week-old mice were subjected to either transverse aortic constriction (TAC) or sham surgery, then they were administered QU or saline. Thereafter, cardiac function and cardiac hypertrophy were accessed. In vitro, cardiac fibroblasts (CFs) were treated with angiotensin II (Ang II) with or without QU. Western blot, qPCR, EdU incorporation assay, and immunofluorescence staining analysis were used to investigate the molecular and cellular features. RESULTS: For the TAC mouse model, cardiac fibrosis was alleviated by QU. The study revealed that the trans-differentiation and proliferation of CFs promoted by Ang II would be reversed by QU in vitro. Mechanistically, QU exerted the anti-fibrotic effect by regulating the SIRT3/TGF-β/Smad3 signaling pathway. CONCLUSION: Quercetin protects against cardiac fibrosis by mediating the SIRT3 signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Xinhua Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Neurology, Xinhua Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Cardiology, Xinhua Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China. wangyaosheng@xinhuamed.com.cn.
- Clinical Research & Innovation Unit, Xinhua Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China. wangyaosheng@xinhuamed.com.cn.
ORCID-Profile: Yao-Sheng Wang
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Health Commission
- High-level University Construction Project of Shanghai City
- Chongming Hospital affiliated with Shanghai University of Medicine and Health Sciences
Zitieren
APA
Lin, D. W., Jiang, Y. W., Wu, C., Zhang, H., Li, Y. Z., & Wang, Y. S. (2025). Quercetin Alleviates Cardiac Fibrosis via Regulating the SIRT3 Signaling Pathway. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-024-07658-x
Vancouver
Lin DW, Jiang YW, Wu C, Zhang H, Li YZ, Wang YS. Quercetin Alleviates Cardiac Fibrosis via Regulating the SIRT3 Signaling Pathway. Cardiovascular Drugs and Therapy. 2025. doi:10.1007/s10557-024-07658-x
BibTeX
@article{Lin2025,
author = {Lin, Da-Wei and Jiang, Yi-Wen and Wu, Chen and Zhang, Hao and Li, Ying-Ze and Wang, Yao-Sheng},
title = {Quercetin Alleviates Cardiac Fibrosis via Regulating the SIRT3 Signaling Pathway},
journal = {Cardiovascular Drugs and Therapy},
year = {2025},
doi = {10.1007/s10557-024-07658-x}
}
EUVIMED